MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
325M
P/E Ratio
68.33
Total Cash
N/A
Projected Growth
N/A
Total Debt
60.5M
Revenue
N/A
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
8.97 USD as % of share price
Fundamentals
RIGL
Capitalization
325M
P/E Ratio
68.33
Risk (Beta)
0.57
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
60.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.97%
Revenue
N/A
ROE
N/A
Book Value
-31.67M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
175K
Current Ratio
1.26
Current Revenue Per Employee
200911.56
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
93.14
Revenue To Assets
N/A
Shares Held By Institutions
180M
Shares Outstanding - Current
17.6M
Total Liabilities
158M
Total Volume MTD
N/A
Value
-1
Gain YTD
27.241
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com